Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-02-02 @ 5:54 PM
Study NCT ID:
NCT01709734
Status:
TERMINATED
Last Update Posted:
2023-03-15
First Post:
2012-10-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
Sponsor:
LTN PHARMACEUTICALS, INC.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TOK-200-10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None